Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins
- 6 May 2003
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 2 (6) , 332-338
- https://doi.org/10.1016/s1568-9972(03)00049-1
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase InhibitorsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- AtherosclerosisCell, 2001
- Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbitsAtherosclerosis, 2001
- Changing concepts of atherogenesisJournal of Internal Medicine, 2000
- Current Perspectives on StatinsCirculation, 2000
- The evolving role of statins in the management of atherosclerosisJournal of the American College of Cardiology, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase InhibitorsCirculation, 1998
- Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide SynthaseJournal of Biological Chemistry, 1997
- Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 MonthCirculation, 1997